⌘K

Login Start Free

Home/Filings/4/0000950170-25-073954

4//SEC Filing

Barry Richard 4

Accession 0000950170-25-073954

CIK 0000873303other

View on SEC.gov Company Profile

Filed

May 18, 8:00 PM ET

Accepted

May 19, 7:32 AM ET

Size

8.0 KB

Accession

0000950170-25-073954

Insider Transaction Report

Form 4

Period: 2025-05-16

Sarepta Therapeutics, Inc.SRPT

Director

Transactions

Exercise/Conversion
Common Stock
2025-05-16$32.63/sh+12,350$402,981→ 2,966,667 total
Exercise/Conversion
Stock Option (right to buy)
2025-05-16−12,350→ 0 total
Exercise: $32.63From: 2018-03-10Exp: 2027-03-10→ Common Stock (12,350 underlying)

Holdings

Common Stock
(indirect: By Trust)
240,000
Common Stock
(indirect: By LLC)
10,000

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1

filerCIK 0001562371

Filing Metadata

Form type: 4
Filed: May 18, 8:00 PM ET
Accepted: May 19, 7:32 AM ET
Size: 8.0 KB

View on SEC.gov